Skip to main content

LOS ANGELES CAPITAL MANAGEMENT LLC

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1177206 LOS ANGELES, CA

Position in RIGL

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$2,423,784
-$405,565 QoQ
Shares Held
89,637
+35.7% QoQ
Ownership
0.480%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 25% Shared 0% None 75%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,423,784 89,637
2025-12-31 $2,829,349 66,060
2025-09-30 $1,956,838 69,073
2025-06-30 $1,542,378 82,348
2025-03-31 $1,879,145 104,455
2024-12-31 $1,446,536 86,001
2024-09-30 $1,205,442 74,502
2024-06-30 $455,453 55,408
2024-03-31 $892,622 603,123
2023-12-31 $586,395 404,411
2023-09-30 $436,763 404,411
2023-06-30 $520,471 403,466
2023-03-31 $513,654 389,132
2022-12-31 $602,383 401,589
2022-09-30 $333,042 282,239
2022-06-30 $276,204 244,429
2022-03-31 $752,071 251,529
2021-12-31 $666,551 251,529
2021-09-30 $913,050 251,529
2021-06-30 $1,193,973 275,109
2021-03-31 $983,246 287,499
2020-12-31 $2,895,973 827,421
2020-09-30 $2,259,340 941,392
2020-06-30 $1,722,121 941,050
2020-03-31 $851,267 545,684